Immediate Repair Successful After Urethral Injury - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Immediate Repair Successful After Urethral Injury

Case report described successful immediate reconstruction of a membranous urethral injury recognized during rectal cancer surgery.

  • By

  • Mouj Hijazi

  • July 2, 2026

  • 3 min

Share

Objective:

To report on the outcomes of immediate urethral reconstruction following a urethral injury during rectal cancer surgery.

Approach:
  • Case Report: Describes a 57-year-old male patient with advanced rectoanal cancer who underwent laparoscopy-assisted abdominoperineal resection and sustained a partial tear of the membranous urethra.
Key Findings:
  • Immediate urethral reconstruction resulted in preserved urinary function.
  • No evidence of stricture or incontinence was observed through 4 years of follow-up.
  • The injury was repaired using five interrupted absorbable sutures with confirmed watertight closure.
Interpretation:

Urethral injury during rectal surgery may be more common than previously recognized, with reported incidences ranging from 0.1% to 2%.

Limitations:
  • The study is based on a single case report.
  • Further research is needed to generalize findings.
Conclusion:

Immediate urethral reconstruction for urethral injury during rectal surgery can yield satisfactory outcomes.

Sources:

Original Source(s)

Immediate Repair Successful After Urethral Injury

  • by Mouj Hijazi

  • July 2, 2026

Related Content

FDA Approves Melanoma BRAF Companion Test

The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.

New CDC Report Tracks US Mortality Trends

The annual provisional report summarizes changes in mortality rates, demographic patterns, and leading causes of death during 2025.

Newborn variants may flag childhood cancer predisposition

Targeted sequencing identified cancer-risk variants in about 7% of pediatric patients who later developed early-onset solid or brain malignancies.